ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,976Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 337

$520K Total Retail Price of All Prescriptions

Rank: 67 out of 337

358 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 358 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,184 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 360 301 1 2
LEVOTHYROXINE SODIUM 354 251 2 5
OMEPRAZOLE 316 277 3 4
SIMVASTATIN 291 244 4 1
ATORVASTATIN CALCIUM 240 207 5 7
ATENOLOL 240 206 5 10
FUROSEMIDE 231 177 7 8
HYDROCODONE-ACETAMINOPHEN 216 105 S3 8 13
CRESTOR 210 194 9 29
AMLODIPINE BESYLATE 204 190 10 3
METFORMIN HCL ER 194 168 11 52
ZOLPIDEM TARTRATE 161 144 12 23
HYDROCHLOROTHIAZIDE 134 115 13 9
CITALOPRAM HBR 132 118 14 17
METOPROLOL TARTRATE 114 103 15 6
LOSARTAN POTASSIUM 111 104 16 15
BENICAR 90 89 17 110
CYCLOBENZAPRINE HCL 89 41 R 18 103
LEVOXYL 87 87 19 90
CYMBALTA 87 22 19 59
GABAPENTIN 85 63 21 20
NEXIUM 83 43 22 56
VENLAFAXINE HCL ER 81 39 23 86
PANTOPRAZOLE SODIUM 79 75 24 36
BYSTOLIC 76 76 25 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 72 26 31
SYNTHROID 74 63 27 41
LIPITOR 71 66 28 33
SERTRALINE HCL 70 45 29 18
FENOFIBRATE 67 30 30 48
CARVEDILOL 60 59 31 73
TRAZODONE HCL 58 28 32 16
IBUPROFEN 58 28 32 64
ALENDRONATE SODIUM 53 36 34 19
OXYCODONE-ACETAMINOPHEN 53 19 S2 34 84
ESCITALOPRAM OXALATE 51 43 36 66
PRAVASTATIN SODIUM 50 38 37 14
TAMSULOSIN HCL 50 37 37 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.